https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
0
0
12/8/23 at 4:00pm
Organization
FDA.gov
Author
Office of the Commissioner
39 words
0
Comments
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
You are the first to view
Create an account
or login to join the discussion